南京诺唯赞生物科技股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告

Group 1 - The company approved a share repurchase plan on June 19, 2025, with a budget between RMB 5 million and RMB 10 million, aiming to buy back part of its issued A-shares at a price not exceeding RMB 30 per share within 12 months [1] Group 2 - As of January 30, 2026, the company has repurchased a total of 127,703 shares, representing 0.03% of the total share capital of 397,734,544 shares, with a total expenditure of RMB 2,999,704.25 [2] Group 3 - The company will adhere to relevant regulations during the repurchase period and will make decisions based on market conditions, ensuring timely disclosure of the progress of the share repurchase [3]